|
⚲
|
| Keyboard |
| Mottola Frank
✚
|
|
|---|---|
| CIK # | 0001804567 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001804567] | |
| 4 | [0001804567] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Supernus Pharmaceuticals Inc | |
| Mottola Frank |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-09 | Sell | 1,623 | $53.65 | 87,074 |
|
Supernus Pharmaceuticals Inc SUPN
Performance Share Unit · derivative
|
2026-03-06 | Option exercise | 3,750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-06 | Option exercise | 3,750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-06 | Tax withheld | 1,793 | $54.73 | 98,131 |
|
Supernus Pharmaceuticals Inc SUPN
Performance Share Unit · derivative
|
2026-02-28 | Grant | 3,750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-25 | Disposed to issuer | 1,875 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-25 | Grant | 1,875 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-25 | Tax withheld | 977 | $50.69 | 49,524 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Tax withheld | 368 | $50.86 | 18,716 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 1,250 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 1,125 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 1,250 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Tax withheld | 603 | $51.35 | 30,964 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 750 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 1,125 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Tax withheld | 670 | $50.86 | 34,076 |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-18 | Grant | 3,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 13,500 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Employee Stock Option (Right to Buy) · derivative
|
2025-12-19 | Option exercise | 15,000 | $0.00 | |
| showing 20 of 83 most recent transactions | |||||